Endosc Int Open Gastroenterologists used to refer patients with GIST to surgery. Recently, third-space endoscopy is progressively increasing all over the world. Different methods of endoscopic resection of GIST have been proposed namely Endoscopic Full Thickness Resection (EFTR) and Submucosal Tunnel Endoscopic Resection (STER). Philip Wai Yan Chiu and his colleagues from Hong Kong retrospectively reviewed 46 patients with GIST less than 4cm and compared STER with EFTR. Patients who received EFTR had longer hospital stays and slower resumption of diet compared to those who underwent STER. EFTR achieved a significantly higher rate of en-bloc resection compared to STER for treatment of gastric GIST.
Read More
Cancer Network Overall survival and progression-free survival rates were improved when first-line nivolumab (Opdivo) plus chemotherapy was given to patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma, according to a study presented at the 2024 Gastrointestinal Cancers Symposium.
Read More
University of Tsukuba via Medical Xpress Ulcerative colitis is a chronic colitis of indeterminate origin, characterized by continuous inflammation spreading from the rectum. Common symptoms include diarrhea, bloody stool and bowel urgency. The initial treatment goal is to alleviate these clinical symptoms; however, the ultimate aim is to achieve a thorough resolution of the endoscopic inflammation of the colonic mucosa.Read More
Healio The FDA has granted breakthrough device designation to Amadix’s PreveCol, a blood test for early detection of colorectal cancer, intended to screen adults aged 45 years or older without apparent symptoms, according to a company release.Read More
Gastroenterology & Endoscopy News Two different monoclonal antibodies targeting the interleukin-23 p19 subunit achieved all of their efficacy end points in their respective placebo-controlled, phase 3 induction trials of ulcerative colitis patients with advanced and largely refractory disease.Read More
News-Medical A study published in The Lancet Gastroenterology and Hepatology estimated the lifetime risk of gastrointestinal cancer and associated mortality, highlighting that gastrointestinal cancers account for one-fourth of all cancer cases and a third of cancer deaths worldwide. This risk is influenced by demographic changes and competing risks from other causes of death.Read More
